Real-World, Open-Label Study of the Efficacy and Safety of a Novel Serum in Androgenetic Alopecia

    Jeffrey Rapaport, Nicholas J Sadgrove, Suleima Arruda, Alyssa Swearingen, Zehara Abidi, Neil Sadick
    TLDR REVIVV® serum improves hair growth and reduces shedding in androgenetic alopecia.
    The study evaluated the efficacy and safety of a novel topical serum, REVIVV®, in treating androgenetic alopecia in 150 participants. The serum, containing a proprietary blend of phytochemicals, was applied twice daily for 8 weeks. Results showed significant improvements in hair growth and reduced shedding. All participants found the serum easy to use and expressed intentions to continue its use. The findings suggest that REVIVV® is effective and has positive cosmetic properties, warranting further clinical evaluation.
    Discuss this study in the Community →

    Related Community Posts Join

    6 / 1000+ results

    Related Research

    10 / 10 results